CHGCF vs LLY: Which Stock is Better?
Side-by-side comparison of Chugai Pharmaceutical Co. Ltd and Eli Lilly & Co in 2026
CHGCF
Chugai Pharmaceutical Co. Ltd
$60.19
LLY
Eli Lilly & Co
$927.03
Key Metrics Comparison
| Metric | CHGCF | LLY | Winner |
|---|---|---|---|
| Market Cap | $99.06B | $829.71B | LLY |
| P/E Ratio | 36.04 | 40.38 | CHGCF |
| EPS (TTM) | $1.67 | $22.96 | LLY |
| Revenue Growth | 0.1% | 0.4% | LLY |
| Gross Margin | 71.1% | 83.0% | LLY |
Analyze CHGCF
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CHGCF or LLY a better investment?
Comparing CHGCF and LLY: Chugai Pharmaceutical Co. Ltd has a market cap of $99.06B while Eli Lilly & Co has $829.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CHGCF and LLY?
CHGCF (Chugai Pharmaceutical Co. Ltd) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CHGCF or LLY?
Based on P/E ratios, CHGCF trades at a lower multiple (36.0x vs 40.4x).
Which is growing faster: CHGCF or LLY?
LLY has higher revenue growth at 0.4% vs 0.1% for CHGCF.
Which company is more profitable: CHGCF or LLY?
Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 71.1% for CHGCF.
Which is the larger company: CHGCF or LLY?
Eli Lilly & Co (LLY) is larger with a market cap of $829.71B compared to $99.06B for CHGCF.
Should I buy CHGCF or LLY in 2026?
Both CHGCF and LLY have investment merit. CHGCF trades at $60.19 while LLY trades at $927.03. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CHGCF and LLY stock?
Key differences: Market Cap ($99.06B vs $829.71B), P/E Ratio (36.0x vs 40.4x), Revenue Growth (0.1% vs 0.4%), Gross Margin (71.1% vs 83.0%).